![Jason Hoitt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Hoitt
Corporate Officer/Principal at
STOKE THERAPEUTICS, INC.
Net worth: 336 231 $ as of 2026-06-29
Profile
Jason Hoitt currently works at Stoke Therapeutics, Inc., as Chief Patient Officer from 2025.
Mr. Hoitt also formerly worked at Sarepta Therapeutics, Inc., as Head-US Sales from 2013 to 2017, Insmed, Inc., as Vice President & Head-US Sales, Dova Pharmaceuticals, Inc., as Chief Commercial Officer from 2018 to 2019, and Provention Bio, Inc., as Chief Commercial Officer from 2020 to 2023.
Mr. Hoitt received his undergraduate degree in 1999 from College of the Holy Cross (Massachusetts).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-30 | 10,276 ( 0.02% ) | 336 231 $ | 2026-06-29 |
Jason Hoitt active positions
| Companies | Position | Start |
|---|---|---|
| STOKE THERAPEUTICS, INC. | Corporate Officer/Principal | 2024-04-14 |
Former positions of Jason Hoitt
| Companies | Position | End |
|---|---|---|
| PROVENTION BIO, INC. | Corporate Officer/Principal | 2023-05-31 |
| DOVA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2019-11-11 |
| INSMED INCORPORATED | Sales & Marketing | - |
| SAREPTA THERAPEUTICS, INC. | Sales & Marketing | 2017-04-30 |
Training of Jason Hoitt
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
65
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Insmed, Inc.
 Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs with disorder of low blood platelet count | Health Technology |
Stoke Therapeutics, Inc.
 Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
Provention Bio, Inc.
 Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that engages in intercepting and preventing immune-mediated diseases including type 1 diabetic activities | Health Technology |
- Stock Market
- Insiders
- Jason Hoitt
